Text this: Tumor response and health-related quality of life in clinically selected patients from Asia with advanced non-small-cell lung cancer treated with first-line gefitinib: Post hoc analyses from the IPASS study

Export Ready —  

  ______    _____     _____    _    _             
 /_   _//  |  ___||  / ____|| | || | ||     ___   
   | ||    | ||__   / //---`' | || | ||    /   || 
  _| ||    | ||__   \ \\___   | \\_/ ||   | [] || 
 /__//     |_____||  \_____||  \____//     \__ || 
 `--`      `-----`    `----`    `---`       -|_|| 
                                             `-`